Greenwich LifeSciences Inc. (GLSI) Social Stream
Featured Post From StockTwits About GLSI
$GLSI sorry not GLSI related. BHVN board is dead. What is your opinion of my high level analysis of BHVN at $109.90 at $7.2B value.haikaa, published August 11, 2021
Nurtec just approved for chronic patients on June 2021, was acute use since mid 2020
95% migraine patients can take Nurtec for acute or chronic use
$800 per rx
12.8% prevalence rate in america
with some worst case assumptions:
30% chronic, 70% acute
only 1 rx for acute per year
10% of migraine patients taking it
cut the price of rx by 50%.. $400
quick math shows over $7 billion revenue yes BILLION
now try to do more realistic assumptions and add other pipeline stocks in coming years
do you now see $500 to $800 stock price here?
97% float is own by institutions
There is no shares avail. stock can do +/- $10 in minutes with small sell/buy orders.
accumulate as much as you can.
My avg is 112.70 now.
Hope we see $80s and $90s, so I can bring my avg down to low $100s.
Loading social stream, please wait...